Make your money go further for just 25p per day

PREMIUM
AIM IHT

Big upgrade | Data winner | Bonkers Bargain impresses

03/09/2024 · Concurrent Technologies (CNC)  · Craneware (CRW)  · Intercede Group (IGP)  · Kitwave Group (KITW)  · Midwich (MIDW) 

AIM AIM Inheritance Tax potential UK

Picasso style depiction

News covered here incudes our assessment of impressive results from one of our Bonkers Bargain opportunities. Elsewhere, another of our Bargains is finding life more challenging but the rock-solid balance offers plenty of reassurance. Read on here for our thoughts on this and other news, including encouraging results from a provider of software to the US healthcare sector.


Episode 31 of the Investor’s Champion Podcast

In this episode of the Investors Champion Podcast, Chris and Lee delve into key market movers, including Nvidia's impressive quarterly results and Warren Buffett's Berkshire Hathaway crossing the $1 trillion valuation mark.

The discussion also covers smaller UK companies including Aquis Exchange, Focusrite, H&T Group and Naked Wines. Listen here.

Onto our thoughts on the latest news...

Concurrent Tech: shares climb to new highs

Shares in Concurrent Technologies…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Concurrent Technologies

Grim greetings | Pub value | 10% dividend yield

17/01/2025 · Company Insights

News covered here includes our assessment of a positive Christmas trading update from a well-regarded and…


Big upgrade | Data winner | Bonkers Bargain impresses

03/09/2024 · Company Insights

News covered here incudes our assessment of impressive results from one of our Bonkers Bargain opportunities.…


More on Craneware

AIM new arrival | Excellent update | Big warning

14/01/2025 · Company Insights

2024 was another difficult year for London’s junior stock market with plenty of departures and few…


Outrageous remuneration | Fabulous results | Cracking bargain

14/11/2024 · Company Insights

News covered here includes our assessment of fabulous results from an AIM listed investment manager, which…


More on Intercede Group

Defence delights | Big dividends | Modest ratings

09/01/2025 · Company Insights

A small company covered here supporting the defence sector continues to do nicely, securing another important…


Bigger is not necessarily better

27/11/2024 · Company Insights

News covered here includes our assessment of results from a cracking little automotive engineering business, although…


More on Kitwave Group

Challenging outlooks | Reassuringly boring | Hidden value

07/11/2024 · Company Insights

News covered here includes our assessment of two small caps facing challenging markets. Elsewhere, a fast…


Big upgrade | Data winner | Bonkers Bargain impresses

03/09/2024 · Company Insights

News covered here incudes our assessment of impressive results from one of our Bonkers Bargain opportunities.…


More on Midwich

Excellent results, but nobody is looking!

21/10/2024 · Company Insights

If you need any encouragement that AIM is more than simply about tax planning, several companies…


Big upgrade | Data winner | Bonkers Bargain impresses

03/09/2024 · Company Insights

News covered here incudes our assessment of impressive results from one of our Bonkers Bargain opportunities.…


More Company Insights

7% dividend yield | Hostel happiness | Another AIM leaver

Medical advances | Stonking Small Cap update | Measured growth

Sign-up to our free email updates

SIGN UP